NASDAQ$BIRD
Allbirds Inc · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
Allbirds reported Q2 2025 a net loss of $15.5M, diluted EPS of $-1.92.
For Q2 2025, Allbirds reported net loss was $15.5M, diluted EPS was $-1.92. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Net loss $15.5M.
- Diluted EPS $-1.92.
- MD&A highlights operating priorities, liquidity, and sector risks.
Headline financials
Revenue & EPS history
Allbirds · Revenue · Quarterly
$39.7M
Forward guidance
Biopharma outlook emphasizes pipeline milestones, launch uptake, and R&D spend.
Tailwinds
- Clinical data and partnership economics.
- Cash runway supports key readouts.
Headwinds
- Trial risk and regulatory timelines.
- Competition and reimbursement pressure.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2025
-8.6%
Avg return
Earnings day
-8.6%
Avg return
5 days after
-1.1%
Avg return
30 days after
25%
6 / 24 earnings
Positive
+24.4%
Q4 2019
Best reaction
-51.2%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.8% | -13.7% | -21.5% | |
| Q4 2025 | +3.6% | +10.9% | +252.1% | |
| Q3 2025 | -7.2% | -28.2% | -39.7% | |
| Q2 2025 | -29.4% | -27.9% | -36.2% | |
| Q1 2025 | -2.4% | +23.8% | +58.0% | |
| Q4 2024 | -13.1% | -13.5% | -27.6% | |
| Q3 2024 | -23.2% | -29.7% | -30.9% | |
| Q2 2024 | +8.2% | +6.5% | -7.8% | |
| Q1 2024 | -10.4% | +2.9% | -19.4% | |
| Q4 2023 | -9.6% | -12.0% | -24.5% | |
| Q3 2023 | -23.9% | -29.3% | +11.9% | |
| Q2 2023 | +23.9% | +18.7% | -6.0% | |
| Q1 2023 | -6.4% | -4.9% | +2.6% | |
| Q4 2022 | -51.2% | -56.4% | -55.1% | |
| Q3 2022 | -17.2% | -6.6% | -5.6% | |
| Q2 2021 | -17.5% | -7.2% | -28.7% | |
| Q2 2022 | -13.1% | -0.2% | -23.0% | |
| Q1 2021 | -7.5% | +0.2% | +8.8% | |
| Q1 2022 | -19.1% | -13.8% | +4.7% | |
| Q4 2019 | +24.4% | +16.5% | +0.4% | |
| Q4 2021 | +0.0% | -8.1% | -29.6% | |
| Q3 2020 | +1.4% | -5.2% | +3.5% | |
| Q4 2020 | +1.4% | -5.2% | +3.5% | |
| Q3 2021 | -14.7% | -24.6% | -15.2% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro